CAR T Vision

CAR T Vision is uniting diverse stakeholders around the shared goal of ensuring every eligible patient has the opportunity for cure with CAR T-cell therapy. The Vision is to double the proportion of eligible patients treated with CAR T-cell therapy by 2030. An independent Steering Committee comprised of leadership from top North American and European patient advocacy groups, medical society organizations, academic and community treatment centers, health technology assessment, policy and other subject matter experts, working together to address current challenges to access and unite the CAR T-cell community to act. To learn more about CAR T Vision, read our new report and join the growing coalition of Vision endorsers, visit www.CARTVision.com. This report and the initial activities of the CAR T Vision Steering Committee have been funded by Gilead and Kite, as the inaugural supporter of the CAR T Vision.